Research programme: ring expanded nucleosides and nucleotides - Nabi

Drug Profile

Research programme: ring expanded nucleosides and nucleotides - Nabi

Alternative Names: Nabi 3700001; RENS - Nabi; Ring Expanded Nucleosides and Nucleotides - Nabi

Latest Information Update: 31 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nabi Biopharmaceuticals
  • Class Nucleosides; Nucleotides
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Hepatitis B; Viral infections

Most Recent Events

  • 31 Dec 2011 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 31 Dec 2011 Discontinued - Preclinical for Hepatitis B in USA (unspecified route)
  • 31 Dec 2011 Discontinued - Preclinical for Viral infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top